Fertility Medical Group, Av. Brigadeiro Luis Antonio, 4545, São Paulo, SP, 01401-002, Brazil.
Fertility Medical Group, Av. Brigadeiro Luis Antonio, 4545, São Paulo, SP, 01401-002, Brazil; Instituto Sapientiae, Centro de Estudos e Pesquisa em Reprodução Humana Assistida, Rua Vieira Maciel, 62, São Paulo, SP, 04503-040, Brazil.
Reprod Biol. 2019 Mar;19(1):55-60. doi: 10.1016/j.repbio.2019.01.004. Epub 2019 Feb 8.
The aim of this study was to investigate which factors contribute to the incidence of biochemical pregnancy (BP) in intracytoplasmic sperm injection (ICSI) cycles. This cohort study included cycles performed from June 2010 to September 2016 in a private, university-affiliated IVF centre. Cycles were split into four groups, depending on the pregnancy outcomes: Clinical Pregnancy (CP, n = 903), Biochemical Pregnancy (BP, n = 55), Miscarriage (MI, n = 142) and Negative Pregnancy (NP, n = 2034). The effects of ovarian stimulation, laboratory data and seminal parameters on pregnancy outcomes were evaluated using adjusted general linear models. Discriminant analyses were conducted to construct a model for pregnancy prediction and to establish cut-offs for BP. The total sperm count (p = 0.035), total and progressive sperm motility (p = 0.001 and p = 0.023, respectively), total motile sperm count (TMSC, p = 0.029) and the endometrial thickness (p < 0.001) were lower among BP group cycles. Lower rates of high-quality cleavage-stage embryos were observed in the BP group compared to CP and MI groups (p < 0.001). In discriminant analyses, cut-offs for BP prediction were established for the following factors: endometrial thickness < 11 mm, sperm motility < 55.5% and total dose of follicle-stimulating hormone (FSH)> 2400 IU. The incidence of biochemical pregnancy was four times higher when the aforementioned factors did not meet the defined cut-offs. The combination of suboptimal endometrial development and poor seminal and embryo quality contribute to an increased incidence of biochemical pregnancy in ICSI cycles.
本研究旨在探讨哪些因素导致卵胞浆内单精子注射(ICSI)周期中生化妊娠(BP)的发生。这是一项回顾性队列研究,纳入了 2010 年 6 月至 2016 年 9 月在一家私立大学附属 IVF 中心进行的周期。根据妊娠结局将周期分为四组:临床妊娠(CP,n=903)、生化妊娠(BP,n=55)、流产(MI,n=142)和未妊娠(NP,n=2034)。使用调整后的一般线性模型评估卵巢刺激、实验室数据和精液参数对妊娠结局的影响。进行判别分析以构建妊娠预测模型并确定 BP 的截止值。BP 组的总精子数(p=0.035)、总活力和前向运动精子比例(p=0.001 和 p=0.023)、总活动精子数(TMSC,p=0.029)和子宫内膜厚度(p<0.001)均较低。与 CP 和 MI 组相比,BP 组的优质胚胎率较低(p<0.001)。在判别分析中,确定了以下因素的 BP 预测截止值:子宫内膜厚度<11mm、精子活力<55.5%和卵泡刺激素(FSH)总剂量>2400IU。当上述因素不符合定义的截止值时,生化妊娠的发生率增加了四倍。不良的子宫内膜发育和较差的精液和胚胎质量的结合导致 ICSI 周期中生化妊娠的发生率增加。